Market Research Report
Smart Pill Market by Components, Tools and Technologies, Production Method, Distribution Channels, and Diagnostics 2022 - 2027
|Smart Pill Market by Components, Tools and Technologies, Production Method, Distribution Channels, and Diagnostics 2022 - 2027|
Published: March 29, 2022
Content info: 131 Pages
Delivery time: 1-2 business days
This report evaluates the smart pills market including the technologies, companies, and solutions for smart pill delivery, monitoring, and diagnostics. The report assesses the impact of smart pills themselves as well as supporting technologies such as IoT, AI, and data analytics.
This report also investigates the use of 3D printing for smart drug delivery, facilitating medical diagnostics on-demand. The report also evaluates the smart pill market by distribution channels including hospitals, clinics, research institutes, and home healthcare delivery.
Smart pill applications investigated include imaging, sensing, and other diagnostic methods as well as ongoing health monitoring and analysis. Smart pill technologies evaluated include those required for endoscopy as well as gastrointestinal monitoring in general.
Additional technologies evaluated include smart pill related data storage and analytics software. The report includes forecasts for 2022 to 2027 analyzing the market outlook and opportunities for smart pills globally and regionally.
Medical Technology (MedTech) is poised to benefit greatly from the convergence of Internet of Things (IoT) technologies including machine-to-machine communications, smart micro or nano-sensors, and other IoT components. Smart pills represent a significant area for next-generation MedTech diagnostic solutions in which ingestible tablets or capsules embedded with sensor, camera, tracker, or microchip are swallowed by a person for purposes of obtaining physiological status and activities.
Combined with IoT, smart pills allow for data capture and monitoring of the subject, regardless of their location. This has substantial implications for various remote healthcare applications including endoscopy, gastrointestinal monitoring in general, as well as other investigative procedures that would otherwise be more invasive, expensive, and time-consuming for the patient. Coupled with next-generation data analytics, healthcare practitioners may leverage these MedTech solutions to provide diagnostics to virtually anyone, anywhere on a substantially lower cost basis.
Since we initiated coverage of this market four years ago, we have identified an additional substantial market driver for smart pills in the wake of the COVID-19 pandemic. We see the need to monitor otherwise healthy people on an ongoing basis due to the substantial amount of disinfectant in the ambient environment.
This is because the gut biome may be impacted by disinfectants due to the die-off of beneficial bacteria in the digestive system of humans. This is especially a concern with particularly sensitive individuals. Accordingly, we see a market driver in terms of monitoring gut health to provide general analytics as well as to identify triggers for the need to apply mediation measures such as the consumption of prebiotics and probiotics to ensure proper gut health.